University at Buffalo pharmaceutical scientist William Jusko has received a nearly $2.9 million Maximizing Investigators’ Research Award (MIRA) to improve understanding of corticosteroid and anticancer drug effects on the body.
Atrophied brain lesion volume is the only marker from MRI scans that can accurately predict which patients with multiple sclerosis will progress to the most severe form of the disease.
This preclinical research demonstrates an effective, minimally invasive method of treating the intractable and growing problem of chronic neuropathic pain.
Kafuli Agbemenu, assistant professor in the UB School of Nursing, has been named one of the first recipients of the Changemakers in Family Planning grant awards from the Society of Family Planning.
Health sciences researchers from around the globe will gather in Buffalo for the 18th Annual Conference for Administrators of Awards from the Fogarty International Center hosted by the University at Buffalo Center for Integrated Global Biomedical Sciences.
A new drug discovered through a research collaboration between the University at Buffalo and Tetra Therapeutics may protect against memory loss, nerve damage and other symptoms of Alzheimer’s disease.
The University at Buffalo School of Nursing has received a $1.35 million grant to increase the number of behavioral health professionals treating opioid and other substance use disorders in Western New York.